AEON Biopharma, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 36.63 million compared to USD 52.56 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -3.07% | -10.73% | -78.06% |
05-09 | AEON Biopharma, Inc. Provides Update on Development Pipeline | CI |
05-03 | US Equity Markets Close Higher Friday Following Weak Jobs Report | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-78.06% | 61.28M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.14% | 22.27B | |
-12.64% | 22.22B | |
-5.29% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- AEON Stock
- News AEON Biopharma, Inc.
- AEON Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023